Literature DB >> 24432223

Mind the gap: Management of an emergent and threatening invasive fungal infection-a case report of rhino-orbital-cerebral and pulmonary mucormycosis.

Joana Cortez1, Bruno Costa Gomes2, Andrea Speidel1, Conceição Peixoto3, Elina Selicka4, Cristina Valente1, Paulo Figueiredo5, António Vieira1.   

Abstract

Mucormycosis is an emergent and threatening invasive fungal invasion underdiagnosed by clinicians due to lack of awareness and aspecific clinical picture. The authors describe a clinical case of a diabetic and cirrhotic patient who developed rhino-orbital-cerebral and pulmonary mucormycosis, non-responsive to treatment. Typical gaps in the management of this deadly disease are addressed. There is a strong need for novel therapies and an expectation that sponsors will recognize the critical need for randomized clinical trials.

Entities:  

Keywords:  Delays; Diabetes; High mortality; Hyperbaric medicine; Mucormycosis; Randomized clinical trials

Year:  2013        PMID: 24432223      PMCID: PMC3885946          DOI: 10.1016/j.mmcr.2013.02.008

Source DB:  PubMed          Journal:  Med Mycol Case Rep        ISSN: 2211-7539


  30 in total

1.  The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.

Authors:  Brad Spellberg; Ashraf S Ibrahim; Peter V Chin-Hong; Dimitrios P Kontoyiannis; Michele I Morris; John R Perfect; David Fredricks; Eric P Brass
Journal:  J Antimicrob Chemother       Date:  2011-09-20       Impact factor: 5.790

Review 2.  Hyperbaric oxygen: applications in infectious disease.

Authors:  Colin G Kaide; Sorabh Khandelwal
Journal:  Emerg Med Clin North Am       Date:  2008-05       Impact factor: 2.264

Review 3.  Diabetes and mucormycosis: a complex interplay.

Authors:  B Rammaert; F Lanternier; S Poirée; R Kania; O Lortholary
Journal:  Diabetes Metab       Date:  2012-03-03       Impact factor: 6.041

Review 4.  A mucormycosis case in a cirrhotic patient successfully treated with posaconazole and review of published literature.

Authors:  Shang-Yi Lin; Po-Liang Lu; Kun-Bow Tsai; Chun-Yu Lin; Wei-Ru Lin; Tun-Chieh Chen; Ya-Ting Chang; Chung-Hao Huang; Chi-Yu Chen; Chung-Chih Lai; Yen-Hsu Chen
Journal:  Mycopathologia       Date:  2012-06-29       Impact factor: 2.574

5.  Future directions in mucormycosis research.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis; Oliver Lortholary; Oliver Lotholary; Brad Spellberg; Georgios Petrikkos; Emmanuel Roilides; Emmanuel Roillides; Ashraf Ibrahim; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

6.  Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis).

Authors:  Thomas J Walsh; Maria N Gamaletsou; Michael R McGinnis; Randall T Hayden; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

7.  [Cerebral hematoma caused by mucormycosis].

Authors:  V Oliveira; A Costa
Journal:  Rev Neurol       Date:  2001 Nov 16-30       Impact factor: 0.870

Review 8.  Mucormycosis treated with posaconazole: review of 96 case reports.

Authors:  Joerg J Vehreschild; Andrea Birtel; Maria J G T Vehreschild; Blasius Liss; Fedja Farowski; Matthias Kochanek; Michal Sieniawski; Angela Steinbach; Kerstin Wahlers; Gerd Fätkenheuer; Oliver A Cornely
Journal:  Crit Rev Microbiol       Date:  2012-08-24       Impact factor: 7.624

Review 9.  Zygomycosis: conventional laboratory diagnosis.

Authors:  C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2009-10       Impact factor: 8.067

10.  Rhizomucor and scedosporium infection post hematopoietic stem-cell transplant.

Authors:  Dânia Sofia Marques; Carlos Pinho Vaz; Rosa Branca; Fernando Campilho; Catarina Lamelas; Luis Pedro Afonso; Manuel Jacome; Eduardo Breda; Eurico Monteiro; António Campos Júnior
Journal:  Case Rep Med       Date:  2011-04-05
View more
  1 in total

1.  Successful treatment of rhino-cerebral mucormycosis with dual antifungal therapy and minimal surgical debridement.

Authors:  Lauren Bougioukas; Cindy D Noyes; Katherine Peterson; Lindsay M Smith; Andrew J Hale
Journal:  IDCases       Date:  2022-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.